Solentim

Solentim is a trusted global leading solution for creating, isolating, and characterizing the highest value cells used in the development of new biopharmaceuticals, including cell and gene therapies, monoclonal antibodies, vaccines, and stem cells. For our clients, which include most of the world’s leading pharmaceutical and biologics companies, we are the preferred partner to ensure the highest level of assurance in cell line development for the production of therapeutic proteins and viral vectors.Our clients develop cell- and antibody-based therapies for a range of diseases, including lymphoma, cancer, Crohn's disease, rheumatoid arthritis, high cholesterol, and asthma.Our proven portfolio of innovative instruments (including VIPS™, Cell Metric®, Cell Metric® CLD, ICON™, and STUDIUS™) is specifically designed for single-cell cloning and ensuring monoclonality.